Cantor Fitzgerald Upgrades Galena Biopharma (GALE) to Hold
Tweet
Share
E-mail
Get Alerts GALE Hot Sheet
Price: $0.21 --0%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Cantor Fitzgerald upgraded Galena Biopharma (NASDAQ: GALE) from Sell to Hold with a price target of $2.00 (unchanged).
For an analyst ratings summary and ratings history on Galena Biopharma click here. For more ratings news on Galena Biopharma click here.
Shares of Galena Biopharma closed at $1.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
- Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
- Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
